UPDATE: JP Morgan On Teva Also Notes 'However, TEVA's near-to-mid-term fundamentals are stabilizing (unlike some of its peers). Further, mgmt's comments on opioids appear encouraging'

Do you like seeing these details as to why an analyst recommended a stock? What could we do to make this product better? Let us know by emailing newsdesk@benzinga.com

Benzinga · 11/12/2019 14:33